Quantitative Structure-Pharmacokinetics Relationships: I. Development of a Whole-Body Physiologically Based Model to Characterize Changes in Pharmacokinetics Across a Homologous Series of Barbiturates in the Rat

By Blakey Graham E.   Nestorov Ivan A.   Arundel Philip A.   Aarons Leon J.   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 3, 1997-06 ,pp. : 277-312

Springer Publishing Company

Access to resources Recommend Favorite

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

By Edginton Andrea N   Theil Frank-Peter   Schmitt Walter   Willmann Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1143-1152

Informa Healthcare

Access to resources Recommend Favorite

Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants

By Parrott Neil  

Clinical Pharmacokinetics, Vol. 50, Iss. 9, 2011-09 ,pp. : 613-623

Adis International

Access to resources Recommend Favorite

Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs

By Willmann Stefan   Höhn Karsten   Edginton Andrea   Sevestre Michael   Solodenko Juri   Weiss Wolfgang   Lippert Jörg   Schmitt Walter  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 3, 2007-06 ,pp. : 401-431

Springer Publishing Company

Access to resources Recommend Favorite

Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic Modelling

By Edginton Andrea N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite